FRANCESKA SEVERE-DEJOIE: Open Payments
NPI 1265192314 · BREINIGSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 66 payments from 18 companies in 2025. Trend: 2023 $1,085 · 2024 $1,662 · 2025 $2,524
Food & beverage: $1,321Long term medical supply or device loan: $1,180Education: $23
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 31 | $1,412 |
| AstraZeneca Pharmaceuticals LP | 9 | $242 |
| PFIZER INC. | 3 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $143 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Daiichi Sankyo Inc. | 4 | $99 |
| ABBVIE INC. | 3 | $60 |
| Incyte Corporation | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 1 | $37 |
| Janssen Biotech, Inc. | 2 | $34 |
Products named: KISQALI, PYRUKYND, IMFINZI, XTANDI, ENHERTU, Fabhalta, Vanflyta, IBRANCE.
Industry payments across PA — which companies pay providers there.
